Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 80 /hr
Hire Dr. Kimberly B.
United States
USD 80 /hr
Medical Science Writer: 20+ years of neuroscience research experience (and a proclivity for statistics)
Profile Summary
Subject Matter Expertise
Services
Work Experience
Contract Science Writer
JoVE
November 2017 - Present
Scientific Affairs
Aytu BioScience
January 2015 - December 2016
Assistant Professor
University of Colorado Anschutz Medical Campus
2006 - 2014
Instructor
University of Colorado Health Science Center
2002 - 2004
Education
PhD (Psychology)
University of South Florida
September 1995 - December 1998
MS (Psychology)
University of South Florida
August 1993 - June 1995
BS (Psychology)
Colorado State University
August 1988 - June 1992
Certifications
- Certification details not provided.
Publications
JOURNAL ARTICLE
(2018). Semen quality and infertility status can be identified through measures of oxidation-reduction potential . Andrologia.
(2018). Oxidation Reduction Potential (ORP) is Predictive of Complications Following Pediatric Cardiac Surgery . Pediatric cardiology.
(2017). Poor acute outcome in congestive heart failure is associated with increases in the plasma static oxidation-reduction potentials (sORP) in men but not in women . Redox report : communications in free radical research.
(2016). Oxidation-reduction potential of semen: what is its role in the treatment of male infertility? . Therapeutic advances in urology.
(2016). Oxidation-Reduction Potential as a Biomarker for Severity and Acute Outcome in Traumatic Brain Injury . Oxidative medicine and cellular longevity.
(2015). A potential compensatory role for endogenous striatal tyrosine hydroxylase-positive neurons in a nonhuman primate model of Parkinson's disease . Cell transplantation.
(2014). Hydrogel formulation determines cell fate of fetal and adult neural progenitor cells . Stem cell research.
(2013). Comparison of fetal mesencephalic grafts, AAV-delivered GDNF, and both combined in an MPTP-induced nonhuman primate Parkinson's model . Molecular therapy : the journal of the American Society of Gene Therapy.
(2012). Modulating cognitive deficits and tau accumulation in a mouse model of aging Down syndrome through neonatal implantation of neural progenitor cells . Experimental gerontology.
(2012). Defining and designing polymers and hydrogels for neural tissue engineering . Neuroscience research.
(2012). Effects of neonatal neural progenitor cell implantation on adult neuroanatomy and cognition in the Ts65Dn model of Down syndrome . PloS one.
(2011). Control of neural cell composition in poly(ethylene glycol) hydrogel culture with soluble factors . Tissue engineering. Part A.
Lampe KJ, Kern DS, Mahoney MJ, Bjugstad KB(2011). The administration of BDNF and GDNF to the brain via PLGA microparticles patterned within a degradable PEG-based hydrogel: Protein distribution and the glial response . Journal of biomedical materials research. Part A.
Bjugstad KB, Lampe K, Kern DS, Mahoney M(2010). Biocompatibility of poly(ethylene glycol)-based hydrogels in the brain: an analysis of the glial response across space and time . Journal of biomedical materials research. Part A.
(2010). Effect of macromer weight percent on neural cell growth in 2D and 3D nondegradable PEG hydrogel culture . Journal of biomedical materials research. Part A.
(2010). Impact of degradable macromer content in a poly(ethylene glycol) hydrogel on neural cell metabolic activity, redox state, proliferation, and differentiation . Tissue engineering. Part A.
(2010). Cellular repair in the parkinsonian nonhuman primate brain . Rejuvenation research.
(2009). Embryonic substantia nigra grafts in the mesencephalon send neurites to the host striatum in non-human primate after overexpression of GDNF . The Journal of comparative neurology.
(2009). Development of porous PEG hydrogels that enable efficient, uniform cell-seeding and permit early neural process extension . Acta biomaterialia.
(2008). Human neural stem cells migrate along the nigrostriatal pathway in a primate model of Parkinson's disease . Experimental neurology.
Elsworth JD, Redmond DE, Leranth C, Bjugstad KB, Sladek JR, Collier TJ, Foti SB, Samulski RJ, Vives KP, Roth RH(2008). AAV2-mediated gene transfer of GDNF to the striatum of MPTP monkeys enhances the survival and outgrowth of co-implanted fetal dopamine neurons . Experimental neurology.
(2008). Biocompatibility of PEG-based hydrogels in primate brain . Cell transplantation.
(2008). Embryonic substantia nigra grafts show directional outgrowth to cografted striatal grafts and potential for pathway reconstruction in nonhuman primate . Cell transplantation.
(2007). Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells . Proceedings of the National Academy of Sciences of the United States of America.
(2006). Infant mice with glutaric acidaemia type I have increased vulnerability to 3-nitropropionic acid toxicity . Journal of Inherited Metabolic Disease.
(2005). AAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCL . Gene therapy.
(2005). Neural stem cells implanted into MPTP-treated monkeys increase the size of endogenous tyrosine hydroxylase-positive cells found in the striatum: a return to control measures . Cell transplantation.
(2004). Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial . Archives of general psychiatry.
(2004). Intracerebroventricular infusions of gp120 inhibit weight gain and induce atrophy in the hippocampus and neostriatum without affecting cognition . Journal of neuro-AIDS.
(2003). Do patients with Parkinson's disease benefit from embryonic dopamine cell transplantation? . Journal of neurology.
(2002). Xenografts of MHC-deficient mouse embryonic mesencephalon improve behavioral recovery in hemiparkinsonian rats . Cell transplantation.
(2001). IGF-1 and bFGF reduce glutaric acid and 3-hydroxyglutaric acid toxicity in striatal cultures . Journal of Inherited Metabolic Disease.
(2000). CPI-1189 prevents apoptosis and reduces glial fibrillary acidic protein immunostaining in a TNF-alpha infusion model for AIDS dementia complex . Journal of neurovirology.
(2000). Predicting therapy duration from therapist experience and client psychopathology . Journal of clinical psychology.
(2000). Age at symptom onset predicts severity of motor impairment and clinical outcome of glutaric acidemia type 1 . The Journal of pediatrics.
(1999). In vitro and in vivo studies investigating possible antioxidant actions of nicotine: relevance to Parkinson's and Alzheimer's diseases . Biochimica et biophysica acta.
(1999). Intravascular beta-amyloid infusion increases blood pressure: implications for a vasoactive role of beta-amyloid in the pathogenesis of Alzheimer's disease . Neuroscience letters.
(1999). Intravascular infusions of soluble beta-amyloid compromise the blood-brain barrier, activate CNS glial cells and induce peripheral hemorrhage . Brain research.
(1999). Adaptation of the circular platform spatial memory task for mice: use in detecting cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease . Journal of neuroscience methods.
(1999). Evidence that oxidative stress is associated with the pathophysiology of inherited hydrocephalus in the H-Tx rat model . Experimental neurology.
(1998). Preventive actions of a synthetic antioxidant in a novel animal model of AIDS dementia . Brain research.
(1996). Age-dependent neurobehavioral responses by young and mature adult rats to systemic kainic acid . Restorative neurology and neuroscience.